Objective: Eradication of chronic hepatitis C (CHC) infection decreases the incidence of hepatocellular carcinoma (HCC), but a risk remains. We aimed to investigate HCC development-associated factors in CHC patients with sustained virological response (SVR) after antiviral therapies.
Methods: We compared CHC patients achieving SVR from 1996-2016 who did and did not develop HCC.